Literature DB >> 8280820

A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children.

V Tolia1, C H Lin, Y Elitsur.   

Abstract

Faecal impaction with or without encopresis is a very common problem. We performed a randomized, open-label, prospective study to compare the efficacy and acceptability of the treatment of faecal impaction using either mineral oil or pineapple-flavoured isotonic intestinal lavage solution containing polyethylene glycol-3350 (Colyte). Thirty-six patients over 2 years of age were randomized to receive either mineral oil or flavoured lavage solution. The dose of mineral oil was 2 to 8 tablespoons twice a day for two days (17 patients--Group I) and of lavage solution was 20 ml/kg/h for 4 hours on two consecutive days (19 patients--Group II). The patients were assessed for the presence of abdominal faecal masses, presence and consistency of rectal mass, perineal soiling before and two days after either of the randomly assigned treatment. The patients and parents were asked regarding the compliance with treatment, side-effects, number of bowel movements after treatment and willingness to try similar treatment if faecal impaction recurred. Patients in the lavage group had more frequent bowel movements, and showed more effective clearance of abdominal and rectal lumps (P < 0.01) at the time of repeat examination at two days. However, they had some vomiting and were less compliant (P < 0.01) when compared to mineral oil patients. We conclude that balanced lavage solution effectively relieves faecal impaction, however, compliance with its use is poorer than that with mineral oil.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280820     DOI: 10.1111/j.1365-2036.1993.tb00128.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

Review 1.  Liquid paraffin: a reappraisal of its role in the treatment of constipation.

Authors:  F Sharif; E Crushell; K O'Driscoll; B Bourke
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.

Authors:  A Attar; M Lémann; A Ferguson; M Halphen; M C Boutron; B Flourié; E Alix; M Salmeron; F Guillemot; S Chaussade; A M Ménard; J Moreau; G Naudin; M Barthet
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Use of oral GoLytely solution in relief of refractory fecal impaction.

Authors:  F P Tiongco; T K Tsang; J Pollack
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 4.  Constipation in Childhood. An update on evaluation and management.

Authors:  I Xinias; A Mavroudi
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

5.  Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation.

Authors:  E Corazziari; D Badiali; F I Habib; G Reboa; G Pitto; G Mazzacca; F Sabbatini; R Galeazzi; T Cilluffo; I Vantini; E Bardelli; F Baldi
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 6.  Advances in the management of pediatric constipation.

Authors:  S Nurko
Journal:  Curr Gastroenterol Rep       Date:  2000-06

Review 7.  Osmotic and stimulant laxatives for the management of childhood constipation.

Authors:  Morris Gordon; John K MacDonald; Claire E Parker; Anthony K Akobeng; Adrian G Thomas
Journal:  Cochrane Database Syst Rev       Date:  2016-08-17

8.  Childhood constipation: evaluation and management.

Authors:  Dinesh S Pashankar
Journal:  Clin Colon Rectal Surg       Date:  2005-05

9.  Managing functional constipation in children.

Authors:  Anne Rowan-Legg
Journal:  Paediatr Child Health       Date:  2011-12       Impact factor: 2.253

10.  PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial.

Authors:  W Voskuijl; F de Lorijn; W Verwijs; P Hogeman; J Heijmans; W Mäkel; J Taminiau; M Benninga
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.